pioglitazone has been researched along with Atrophic Muscular Disorders in 1 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with pioglitazone (PG), an activator of PPARĪ³, improved the viability of the cellular model of SBMA." | 1.42 | Pioglitazone suppresses neuronal and muscular degeneration caused by polyglutamine-expanded androgen receptors. ( Adachi, H; Iida, M; Ikenaka, K; Katsuno, M; Kishida, K; Kondo, N; Miyazaki, Y; Nakatsuji, H; Sobue, G; Tohnai, G; Watanabe, H; Yamamoto, M, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iida, M | 1 |
| Katsuno, M | 1 |
| Nakatsuji, H | 1 |
| Adachi, H | 1 |
| Kondo, N | 1 |
| Miyazaki, Y | 1 |
| Tohnai, G | 1 |
| Ikenaka, K | 1 |
| Watanabe, H | 1 |
| Yamamoto, M | 1 |
| Kishida, K | 1 |
| Sobue, G | 1 |
1 other study available for pioglitazone and Atrophic Muscular Disorders
| Article | Year |
|---|---|
Pioglitazone suppresses neuronal and muscular degeneration caused by polyglutamine-expanded androgen receptors.
Topics: Animals; Disease Models, Animal; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Muscle, S | 2015 |